drugset
drugset / Trial / NCT01709721

Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration

NCT01709721 ↗

Phase 3 Completed 153 enrolled Piramal Critical Care, Ltd.
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this study is to determine the safety and efficacy of hydromorphone hydrochloride by intrathecal administration using a programmable implantable pump.

Timeline

Start
2013-02
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified — Intrathecal

Indications

chronic pain syndrome